Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: Lung Neoplasms trials

The registry lists 18 Lung Neoplasms studies with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor. 2 are open to participants now and 6 have results posted.

Phase 1 2Phase 2 9No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• DK222 Study at HopkinsRecruitingNCT07140315Phase 1
• Immunobiology Blood and Tissue Collection of Upper Aerodigestive MalignanciesRecruitingNCT05995821
• Improving Cancer On-treatment Symptom ManagementCompletedNCT04589247Results posted
• Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.CompletedNCT01928576Phase 2Results posted
• Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung CancerCompletedNCT01797159Not applicableResults posted
• A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.TerminatedNCT01752023Phase 2Results posted
• Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLCTerminatedNCT00769600Phase 2Results posted
• Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00287989Phase 2Results posted
• PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)TerminatedNCT04524195Phase 1
• Screening for Lung Cancer in the HIV PatientCompletedNCT01748136
• Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00899756
• Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous TreatmentCompletedNCT00673569Phase 2
• Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung CancerTerminatedNCT00465907Phase 2
• Transitoriness in Cancer Patients, Psychosocial Issues in Cancer CareCompletedNCT00364078
• Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00293280Phase 2
• Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By SurgeryCompletedNCT00281970Phase 2
• Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00276588Phase 2
• Broccoli Sprout Extract in Preventing Lung Cancer in SmokersCompletedNCT00255775Not applicable